NLM Digital Collections

Search

Start Over Subjects Medicare Part D -- economics ✖Remove constraint Subjects: Medicare Part D -- economics

41. Rx Price Watch report: retail prices for widely used brand name drugs increase considerably prior to generic competition

Publication:
Washington, D.C. : AARP Public Policy Institute, c2011
Subject(s):
Drug Costs -- trends
Drug Therapy -- statistics & numerical data
Economic Competition
Pharmaceutical Preparations -- economics
Drug Approval
Drug Costs -- statistics & numerical data
Forecasting
Medicare Part D -- economics
Patents as Topic
Humans
United States

43. Prescription drugs: Department of Veterans Affairs paid about half as much as Medicare Part D for selected drugs in 2017 : report to the Ranking Member, Committee on the Budget, U.S. Senate

Publication:
Washington, DC : United States Government Accountability Office, December 2020
Subject(s):
Costs and Cost Analysis -- statistics & numerical data
Drug Costs -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
United States
United States. Department of Veterans Affairs

46. A comparison of brand-name drug prices among selected federal programs

Author(s):
Baker, Colin, author
Laughery, Scott, author
Patel, Yash, author
Publication:
[Washington, DC] : Congressional Budget Office, February 2021
Subject(s):
Drug Costs -- statistics & numerical data
Government Programs -- economics
Medicaid -- economics
Federal Government
Medicare Part D -- economics
Prescription Drugs -- economics
United States
United States. Department of Defense.
United States. Department of Veterans Affairs.

48. High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2021
Subject(s):
Drug Development -- legislation & jurisprudence
Government Regulation
Medicare Part B -- economics
Medicare Part D -- economics
Orphan Drug Production -- economics
United States
United States. Department of Health and Human Services

49. Medicare Part D: a first look at plan offerings in 2016

Author(s):
Hoadley, Jack, author
Cubanski, Juliette, author
Neuman, Tricia, author
Publication:
Menlo Park, CA : Henry J. Kaiser Family Foundation, October 2015
Subject(s):
Insurance Benefits -- economics
Insurance Benefits -- statistics & numerical data
Insurance Coverage -- economics
Insurance Coverage -- statistics & numerical data
Insurance, Pharmaceutical Services -- economics
Insurance, Pharmaceutical Services -- statistics & numerical data
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
United States